Search

Your search keyword '"Neoplasm Proteins therapeutic use"' showing total 2 results
Start Over Descriptor "Neoplasm Proteins therapeutic use" Region australia
2 results on '"Neoplasm Proteins therapeutic use"'

1. Australian data do not support current Pharmaceutical Benefits Scheme criteria for use of tumour necrosis factor-alpha inhibitors in ankylosing spondylitis.

Author

Schachna L and Brown MA

Subjects
Australia, Humans, Pharmaceutical Services economics, Tumor Necrosis Factor Decoy Receptors, Antirheumatic Agents therapeutic use, Neoplasm Proteins therapeutic use, Receptors, Tumor Necrosis Factor, Type II therapeutic use, Spondylitis, Ankylosing drug therapy
Published
2006
Full Text
View/download PDF

2. Subsidised access to TNF-alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?

Author

Mann EL

Subjects
Australia, Humans, Neoplasm Proteins economics, Receptors, Tumor Necrosis Factor, Type II, Treatment Outcome, Tumor Necrosis Factor Decoy Receptors, Arthritis, Rheumatoid drug therapy, Arthritis, Rheumatoid immunology, Health Care Rationing methods, Neoplasm Proteins therapeutic use, Patient Selection, Rheumatoid Factor blood
Published
2005
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results